42 results on '"Tchinda, Joelle"'
Search Results
2. Supplementary Figure 1 from TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer
3. Supplementary Figure 2 from TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer
4. Supplementary Figure 3 from TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer
5. Supplementary Figure 3 from TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer
6. Supplementary Figure 2 from TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer
7. Supplementary Figure 1 from TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer
8. Near-tetraploid T-cell acute lymphoblastic leukaemia in childhood: Results of the AIEOP-BFM ALL studies
9. Association of unbalanced translocation der(1;7) with germline GATA2 mutations
10. Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity
11. Abstract 3194: Development of anin vitrodrug profiling platform with primary Rhabdomyosarcoma cells for tailoring patient-specific treatments
12. Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?
13. Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia
14. Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening
15. Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups
16. Explant culture of sarcoma patients' tissue
17. Somatic Genetic and Epigenetic Architecture of Myelodysplastic Syndromes Arising from GATA2 Deficiency
18. Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options
19. Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing
20. Double hit, triple hit—look for it
21. Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment
22. Abstract 5330: Leukemia initiating cells are frequent and oligoclonal in de novo resistant ALL
23. Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization
24. Targeted therapeutic approach for an anaplastic thyroid cancerinvitroandinvivo
25. Alu elements mediate MYB gene tandem duplication in human T-ALL
26. The Recurrent SET-NUP214 Fusion as a New HOXA Activation Mechanism in Pediatric T-Cell Acute Lymphoblastic Leukemia.
27. In Reply
28. Large Scale Copy Number Variation Upregulates the Expression of MYB in Human T-ALL.
29. Intensification of Induction by High-Dose AraC and Outcome in Older Patients with De-Novo Acute Myeloid Leukemia (AML) and Subsets.
30. Changes in the Hierarchy of Risk Factors with Older Age in De-Novo Acute Myeloid Leukemia (AML).
31. Global variation in copy number in the human genome
32. TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer
33. Double Induction Containing Either Two Courses or One Course of High-Dose Cytarabine Plus Mitoxantrone and Postremission Therapy by Either Autologous Stem-Cell Transplantation or by Prolonged Maintenance for Acute Myeloid Leukemia
34. Hotspots for copy number variation in chimpanzees and humans
35. Double Induction Containing Two Courses Versus One Course of High- Dose AraC/ Mitoxantrone (HAM) and Autologous Stem Cell Transplantation Versus Prolonged Maintenance for Acute Myeloid Leukemia (AML).
36. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
37. Acute myeloid leukemia presenting with a uterus tumor
38. Treatment of AML in biological subgroups
39. Significant Hybridization Differences in Comparative Genomic Hybridization due to Nucleotides Used for DNA Labelling and to DNA Chosen for Cohybridization
40. Cytogenetic Aberrations in Myelodysplastic Syndrome Detected by Comparative Genomic Hybridization and Fluorescence In Situ Hybridization
41. Analysis of hematologic diseases using conventional karyotyping, fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH)
42. Single- and double-color oligonucleotide primed in situ labeling (PRINS): applications in pathology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.